Whole-Genome Sequencing and Genetic Diversity of Human Respiratory Syncytial Virus in Patients with Influenza-Like Illness in Sicily (Italy) from 2017 to 2023

Fabio Tramuto,Carmelo Massimo Maida,Giulia Randazzo,Valeria Guzzetta,Arianna Santino,Rita Li Muli,Claudio Costantino,Giorgio Graziano,Emanuele Amodio,Walter Mazzucco,Francesco Vitale

DOI: https://doi.org/10.3390/v16060851

2024-05-27

Viruses

Abstract:Monitoring the genetic variability of human respiratory syncytial virus (hRSV) is of paramount importance, especially for the potential implication of key antigenic mutations on the emergence of immune escape variants. Thus, to describe the genetic diversity and evolutionary dynamics of hRSV circulating in Sicily (Italy), a total of 153 hRSV whole-genome sequences collected from 770 hRSV-positive subjects between 2017 and 2023, before the introduction of expanded immunization programs into the population, were investigated. The phylogenetic analyses indicated that the genotypes GA.2.3.5 (ON1) for hRSV-A and GB.5.0.5a (BA9) for hRSV-B co-circulated in our region. Amino acid (AA) substitutions in the surface and internal proteins were evaluated, including the F protein antigenic sites, as the major targets of immunoprophylactic monoclonal antibodies and vaccines. Overall, the proportion of AA changes ranged between 1.5% and 22.6% among hRSV-A, whereas hRSV-B varied in the range 0.8–16.9%; the latter was more polymorphic than hRSV-A within the key antigenic sites. No AA substitutions were found at site III of both subgroups. Although several non-synonymous mutations were found, none of the polymorphisms known to potentially affect the efficacy of current preventive measures were documented. These findings provide new insights into the global hRSV molecular epidemiology and highlight the importance of defining a baseline genomic picture to monitor for future changes that might be induced by the selective pressures of immunological preventive measures, which will soon become widely available.

virology

What problem does this paper attempt to address?

The main aim of this paper is to study the whole genome sequences and genetic diversity of the respiratory syncytial virus (hRSV) prevalent in the Sicily region of Italy from 2017 to 2023. Specifically, the research objectives include:

1. **Describing the genetic diversity of hRSV**: Describing the genetic diversity of hRSV by analyzing 153 whole genome sequences collected from 770 hRSV-positive patients. These samples were collected before the introduction of the expanded immunization program.

2. **Monitoring changes in key antigenic sites**: Evaluating amino acid changes in surface and internal proteins, particularly the antigenic sites of the F protein, as these sites are the main targets for prophylactic monoclonal antibodies and vaccines.

3. **Identifying circulating subtypes**: Identifying the subtypes of hRSV-A and hRSV-B co-circulating in the Sicily region during the study period. The results show that GA.2.3.5 (ON1) is the dominant subtype for hRSV-A and GB.5.0.5a (BA9) for hRSV-B.

4. **Analyzing amino acid variations**: Evaluating amino acid variations in the antigenic sites of the F protein and other important proteins to understand whether these variations might affect the effectiveness of existing preventive measures.

5. **Providing new insights into molecular epidemiology**: Providing new insights into the global molecular epidemiology of hRSV by analyzing the whole genome sequences of hRSV and emphasizing the importance of establishing a baseline genomic picture to monitor potential changes driven by the selection pressure of immunoprophylactic measures in the future.

In summary, this paper provides important information for understanding the evolutionary dynamics of hRSV in a specific geographic region through whole genome sequencing and genetic diversity analysis, and offers a scientific basis for future prevention strategies.